6 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Zevalin
Date of authorisation: 16/01/2004, Revision: 21, Authorised, Last updated: 12/12/2017for the public Zevalin ibritumomab tiuxetan This is a summary of the … of the active substance ibritumomab tiuxetan. What is Zevalin used for … ibritumomab tiuxetan … -
List item
Human medicine European public assessment report (EPAR): Yttriga
Date of authorisation: 19/01/2006, Revision: 9, Authorised, Last updated: 14/08/2014 -
List item
Human medicine European public assessment report (EPAR): Carmustine Obvius (updated)
Date of authorisation: 18/07/2018,
, Revision: 3, Authorised, Last updated: 30/01/2020
-
List item
Human medicine European public assessment report (EPAR): Lympreva
Date of refusal: 03/07/2015,
, Refused, Last updated: 17/07/2015
-
List item
Human medicine European public assessment report (EPAR): Gazyvaro
Date of authorisation: 22/07/2014,
, , Revision: 8, Authorised, Last updated: 28/08/2019
-
List item
Referral: Levact
bendamustine, associated names: Ribomustin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 07/07/2010,